Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized TrialLaura E Dichtel, Kathleen E Corey, Melanie S Haines, et al.
American Journal of Veterinary Research|September 2, 2009
Evaluation of quantitative trait loci for hip dysplasia in Labrador RetrieversJanjira Phavaphutanon, Raluca G Mateescu, Kate L Tsai, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|September 24, 2005
Effect of population size on the estimation of QTL: a test using resistance to barley stripe rustM I Vales, C C Schön, F Capettini, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2020
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver DiseaseTakara L Stanley, Lindsay T Fourman, Isabel Zheng, et al.
Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.
Infection Control and Hospital Epidemiology|September 12, 2009
Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workersKathleen E Corey, Julie C Servoss, Deborah R Casson, et al.
The American Journal of Cardiology|April 6, 1999
Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitationK E Corey, C Maynard, O Pahlm, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practicesZobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
Seminars in Liver Disease|October 14, 2022
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?Bing Chen, W H Wilson Tang, Mario Rodriguez, et al.
JCI Insight|May 5, 2017
Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitisW Taylor Kimberly, John F O'Sullivan, Anjali K Nath, et al.
Pageof 22